Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine

Epstein-Barr virus (EBV) is one of the most widespread viruses in the world; more than 90% of the planet’s adult population is infected. Symptomatic primary infection by this Herpesviridae corresponds to infectious mononucleosis (IM), which is generally a benign disease. While virus persistence is o...

Full description

Bibliographic Details
Main Authors: Vincent Jean-Pierre, Julien Lupo, Marlyse Buisson, Patrice Morand, Raphaële Germi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Microbiology
Subjects:
Epstein-Barr virus (human gammaherpesvirus 4)
EBV-associated cancer
glycoproteins
infectious mononucleosis
latency
lytic cycle
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.701611/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2021.701611/full

Similar Items